2001
Analysis of Risk Factors for Fatal Rocky Mountain Spotted Fever: Evidence for Superiority of Tetracyclines for Therapy
Holman R, Paddock C, Curns A, Krebs J, McQuiston J, Childs J. Analysis of Risk Factors for Fatal Rocky Mountain Spotted Fever: Evidence for Superiority of Tetracyclines for Therapy. The Journal Of Infectious Diseases 2001, 184: 1437-1444. PMID: 11709786, DOI: 10.1086/324372.Peer-Reviewed Original ResearchConceptsRisk factorsFatal Rocky Mountain Spotted FeverRocky Mountain Spotted FeverOnset of symptomsCase fatality rateTetracycline-class antibioticsPrimary therapyClinical characteristicsOlder patientsAppropriate therapyRMSF casesNonfatal casesNational surveillanceHigh riskSpotted FeverPatientsEffective antibioticsTherapyDeathFeverAntibioticsTreatmentSymptomsFactorsDisease
1996
Current issues in rabies prevention in the United States health dilemmas. Public coffers, private interests.
Rupprecht C, Smith J, Krebs J, Niezgoda M, Childs J. Current issues in rabies prevention in the United States health dilemmas. Public coffers, private interests. Public Health Reports 1996, 111: 400-7. PMID: 8837628, PMCID: PMC1381782.Peer-Reviewed Original ResearchConceptsHuman rabies deathsDay prophylaxisPublic health costsRabies prophylaxisRabies deathsMedical treatmentAnimal contactDisease preventionHealth dilemmaRabies preventionViral variantsFuture guidelinesAnimal rabies casesHealth costsProphylaxisAnnual human deathsPreventionMajor outbreaksRabies casesAnimal rabiesHuman deathsDeathRabiesYears